Chemed (NYSE:CHE – Get Free Report) will be releasing its earnings data after the market closes on Tuesday, October 29th. Analysts expect Chemed to post earnings of $5.31 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Chemed Trading Up 1.0 %
Shares of NYSE CHE opened at $602.98 on Monday. Chemed has a twelve month low of $516.03 and a twelve month high of $654.62. The firm has a 50-day moving average of $586.25 and a two-hundred day moving average of $569.41. The company has a market capitalization of $9.13 billion, a price-to-earnings ratio of 32.45, a PEG ratio of 2.44 and a beta of 0.44.
Chemed Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were paid a dividend of $0.50 per share. The ex-dividend date was Monday, August 12th. This is a positive change from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed’s dividend payout ratio is currently 10.76%.
Insiders Place Their Bets
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
- Five stocks we like better than Chemed
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- Why Invest in High-Yield Dividend Stocks?
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Investing In Automotive Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.